Last clinically reviewed: 17 June 2026 Published 13 June 2025

Wegovy side effects: what’s normal, what helps, and when to get medical advice

Wegovy side effects are most often digestive symptoms such as nausea, vomiting, diarrhoea, constipation and stomach pain, particularly when treatment starts or the dose increases. [1,2] Headache, tiredness, dizziness, reflux, burping and bloating can also occur. [1] Many common side effects are mild to moderate and settle over time, but some symptoms need prescriber review or urgent medical help. This guide explains what may be expected, what can help, and which warning signs should not be ignored.

Paul John
Written by Paul John MPharm, IP
James Reynolds
Reviewed by James Reynolds MPharm, DipClinPh, PgCert Derm, SCOPE, IP

Key takeaways

  • Wegovy is a once-weekly semaglutide injection supplied as a pre-filled pen in current UK product information. Searches for “Wegovy pill side effects” usually reflect confusion with other medicines or formats.
  • Very common Wegovy side effects include headache, nausea, vomiting, diarrhoea, constipation, stomach pain and feeling weak or tired.
  • Side effects often appear in the first few days or weeks of treatment, or after a dose increase. Many improve as your body adjusts, but persistent, worsening or disruptive symptoms should be discussed with your prescriber.
  • Simple measures such as smaller meals, slower eating, avoiding very rich or greasy food, drinking enough fluid and managing constipation early may help mild symptoms. Do not change your dose or schedule without clinical advice.
  • Seek urgent medical help for severe or persistent abdominal pain, signs of a severe allergic reaction, sudden or rapidly worsening eyesight, severe dehydration, or severe constipation with stomach pain, bloating or vomiting.

Is there currently a Wegovy pill?

No. Current UK product information describes Wegovy FlexTouch as a solution for injection in a pre-filled pen. [1] It is given as a subcutaneous injection once a week, usually into the stomach, thigh or upper arm.

This matters because a large number of people search for Wegovy pill side effects or Wegovy tablet side effects. That wording can lead to the wrong advice. If you have been prescribed a semaglutide tablet, or any other medicine that is not Wegovy, read the patient leaflet for that medicine and ask your prescriber or pharmacist for advice.

Do not assume the dosing instructions or side-effect advice are the same.

Note: In this guide, “Wegovy side effects” refers to Wegovy injection pens used under UK prescribing information, not a pill, tablet or non-prescribed weight-loss product.

Why Wegovy causes side effects

Wegovy contains semaglutide, a GLP-1 receptor agonist. [1,2] It acts on appetite pathways in the brain so that you feel fuller, less hungry and may experience fewer cravings. It should be used alongside a reduced-calorie meal plan and increased physical activity. [1,6]

The same mechanism that helps reduce appetite can also affect the digestive system. [1,2] Nausea, vomiting, diarrhoea, constipation, reflux, burping and bloating are therefore among the most common problems. Side effects are often more noticeable when you first start treatment or when the dose is increased.

This does not mean every symptom is harmless. Digestive side effects can sometimes cause dehydration, and severe abdominal pain can be a sign of pancreatitis or gallbladder problems. The practical aim is to separate mild, expected symptoms from symptoms that need prompt or urgent advice.

When do Wegovy side effects start?

Wegovy side effects can start within the first few days of treatment, but some people notice very little at the starting dose. Others feel symptoms more clearly after moving up to the next dose. This is why side effects are often discussed around week one, the first month, the 0.5 mg dose, the 1 mg dose and later dose increases.

For weight management, Wegovy is usually started at a low dose and increased gradually. The current UK product information describes a schedule beginning at 0.25 mg once weekly and increasing every four weeks until the usual maintenance dose is reached, unless your prescriber advises otherwise. [1,2]

If symptoms become difficult after a dose increase, do not self-adjust the dose, skip doses to “reset”, or take doses closer together. Contact your prescriber. For significant digestive symptoms, the prescriber may need to review whether the dose should be delayed, reduced or managed differently. [2]

Do Wegovy side effects go away?

Many common Wegovy side effects do go away over time. The patient leaflet lists headache, nausea, vomiting, diarrhoea, constipation, stomach pain and feeling weak or tired as very common side effects, and states that these usually go away over time. [1]

That does not mean you should simply put up with symptoms indefinitely. Speak to your prescriber if side effects persist, worsen, interfere with eating or drinking, stop you working or driving safely, or make you unsure whether to continue. Constipation can last longer than nausea or diarrhoea in some people and should be addressed early.

Semaglutide also remains in the body for some time. The professional product information describes an elimination half-life of about one week, with semaglutide present in the circulation for about seven weeks after the last 2.4 mg dose. [2] This means symptoms may not always disappear immediately after a dose change or stopping treatment.

Common Wegovy side effects and what may help

The table below is not a substitute for your patient leaflet or prescriber advice. It is a practical summary of common patterns and sensible next steps. The side-effect categories are based on UK Wegovy patient information, with practical self-care aligned to NHS patient guidance where relevant. [1,7,8,9,10,11,12]

Side effect

What you may notice

What may help or when to ask for advice

Nausea or vomiting

Very common. Often more noticeable after starting treatment or increasing the dose.

Eat smaller meals, stop when full, avoid rich or greasy food, sip fluids. Contact your prescriber if vomiting is repeated, severe, persistent or you cannot keep fluids down.

Diarrhoea

Very common. Can lead to dehydration if severe or prolonged.

Drink fluids. A pharmacist may advise oral rehydration support. Seek advice if diarrhoea is severe, prolonged, bloody, associated with fever, or causing dehydration signs.

Constipation and stomach pain

Very common. Constipation can last longer than other digestive symptoms.

Increase fluids, add fibre gradually if tolerated, keep moving where possible. Contact your prescriber or pharmacist if it does not improve. Seek urgent help if constipation is severe with pain, bloating or vomiting.

Headache

Very common. May be linked to reduced food intake, dehydration or treatment adjustment.

Check fluid intake and regular nutrition. Seek advice for severe, unusual or persistent headache, especially if linked with vision changes or dehydration.

Feeling weak, tired or dizzy

Weakness or tiredness is very common; dizziness is common.

Avoid driving or operating machinery while dizzy. Contact your prescriber if dizziness, weakness or fatigue affects daily activity, causes fainting, or does not improve.

Heartburn, reflux, indigestion, burping, wind or bloating

Common digestive effects.

Try smaller, more frequent meals and avoid late, heavy or trigger meals. Stay upright after eating. Ask a pharmacist or prescriber if symptoms are frequent or painful.

Gallstones

Listed as common in the patient leaflet.

Seek medical advice urgently if you develop strong upper-right abdominal pain, pain spreading to the right shoulder, fever, jaundice, dark urine or pale stools.

How to reduce nausea on Wegovy

Nausea is one of the main reasons people search for Wegovy side-effect advice. The aim is not to force normal portion sizes. Wegovy can make you feel full sooner, so eating past fullness can make nausea worse.

Try smaller meals, eat slowly, avoid very greasy, rich or spicy food while symptoms are active, and pause before going back for more. Plain foods may be easier during a flare. Sipping fluid regularly is usually better tolerated than drinking a large amount at once.

Contact your prescriber if nausea is persistent, severe, associated with repeated vomiting, causing weight loss that feels too rapid, or making it difficult to eat and drink enough. Do not take anti-sickness medicines or over-the-counter remedies routinely without checking they are suitable for you.

How to manage diarrhoea, vomiting and dehydration risk

Vomiting and diarrhoea matter because they can cause dehydration. [1,3,5,7,8] This is especially important if you have kidney problems, take medicines affected by fluid loss, or cannot keep fluids down.

For mild symptoms, prioritise fluids. Oral rehydration products from a pharmacy may be useful if you are losing a lot of fluid through vomiting or diarrhoea. [8] Avoid assuming that severe diarrhoea is just part of the process.

Clinical warning

Seek urgent medical advice if you have repeated vomiting or diarrhoea with signs of dehydration, such as passing very little urine, very dark urine, severe dizziness, confusion, dry mouth, or being unable to keep fluids down. If symptoms are severe or you feel seriously unwell, use NHS 111, urgent care or emergency services as appropriate.

How to handle constipation on Wegovy

Constipation is very common with Wegovy and can be uncomfortable. [1] It may be linked to slower gut movement, reduced food intake, lower fluid intake or changes in fibre.Build fibre gradually rather than suddenly adding large amounts, especially if you are already bloated. Drink enough fluid, keep moving where possible, and ask a pharmacist whether a short-term laxative is suitable if diet and lifestyle measures are not helping. [9]

Do not ignore severe constipation. Seek urgent medical advice if constipation comes with severe stomach pain, bloating, vomiting or an inability to pass wind, because the Wegovy patient leaflet lists bowel obstruction as a possible side effect with frequency not known. [1]

What should you expect in the first week of Wegovy?

In the first week, some people notice reduced appetite and mild nausea. Others notice little change. The starting dose is deliberately low, so a lack of strong effect in week one does not mean the medicine is not working.

Useful things to track from the first dose include your dose, injection day, symptoms, meals that triggered symptoms, bowel pattern, fluid intake and any dizziness, vomiting or diarrhoea. This gives your prescriber better information if symptoms become difficult later.

The first week is also a good time to avoid over-correcting your diet. Very low food intake can worsen headache, tiredness, dizziness and constipation. The goal is steady, tolerable treatment supported by enough fluid, protein, fibre and routine meals, not maximum appetite suppression at any cost.

What to track before contacting your prescriber

You do not need a perfect diary, but a simple symptom record can make the conversation more useful. Track the following if side effects are persistent, worsening or hard to judge:

  • Dose and injection date, including whether symptoms started after a dose increase.
  • Type of symptom, severity, time of day and how long it lasts.
  • Vomiting or diarrhoea frequency, and whether you can keep fluids down.
  • Fluid intake, urine colour and how often you are passing urine.
  • Location and character of any abdominal pain, including whether it spreads to the back or right shoulder.
  • Constipation pattern, bloating, vomiting or inability to pass wind.
  • Dizziness, fainting, weakness, headache or ability to drive safely.
  • Blood glucose readings if you have diabetes and have been told to monitor them.
  • Other medicines, supplements, alcohol intake, missed doses or accidental extra doses.

When to monitor, contact your prescriber or seek urgent help

Use three levels of action. Do not rely on colour or reassurance alone.

  1. Monitor or self-manage mild symptoms if they are expected, improving and not affecting hydration, eating, daily function or safety. Examples include mild nausea, mild constipation without warning signs, or temporary tiredness after starting treatment.
  2. Contact your prescriber or clinician if symptoms persist, worsen, return after each dose increase, interfere with normal activities, make you unsure about continuing, or affect other medical conditions. This includes persistent nausea, repeated reflux, constipation that is not improving, dizziness, weakness, severe headache, or possible medicine interactions.
  3. Seek urgent medical help for the symptoms below. These warning signs are drawn from the Wegovy patient leaflet, MHRA safety communications and NHS guidance on dehydration and gallbladder symptoms. [1,3,4,8,11,12]

Symptom or sign

Why it matters

What to do

Severe, persistent abdominal pain, especially if it spreads to your back, with or without nausea or vomiting

Could be acute pancreatitis, which can be serious and potentially life-threatening.

Stop using Wegovy and seek urgent medical help.

Swelling of the face, lips, tongue or throat; difficulty breathing or swallowing; wheezing; fast heartbeat; pale/cold skin; feeling dizzy or weak

Could be a severe allergic reaction.

Seek immediate medical help. Call 999 if breathing, swelling or collapse symptoms are present.

Sudden loss of vision or rapidly worsening eyesight

Very rare reports link semaglutide with NAION, a serious eye condition.

Urgently contact a doctor, NHS 111, eye casualty or A&E if you cannot get prompt advice.

Repeated vomiting or diarrhoea with very little urine, very dark urine, severe dizziness, confusion or inability to keep fluids down

Could be significant dehydration, which can lead to kidney complications.

Seek urgent clinical advice. Use NHS 111 or urgent care if you are unsure what service to use.

Severe constipation with stomach pain, bloating, vomiting or inability to pass wind

Could suggest bowel obstruction or another serious digestive problem.

Seek urgent medical advice.

Strong upper-right abdominal pain, pain spreading to the right shoulder, fever, yellow skin or eyes, dark urine or pale stools

Could suggest gallbladder inflammation, gallstones blocking bile flow or another urgent abdominal problem.

Seek urgent medical advice. Use NHS 111, urgent care or A&E depending on severity.

Shaking, sweating, confusion, fast heartbeat, vision changes, unusual sleepiness or weakness in someone with diabetes using insulin or a sulfonylurea

Could be low blood sugar, which is more likely when Wegovy is used with some diabetes medicines.

Follow your diabetes hypo plan. Get urgent help if symptoms are severe, you cannot treat them, or consciousness is affected.

Long-term Wegovy side effects and ongoing risks

Questions about long-term Wegovy side effects need a careful answer. Wegovy has known side effects listed in the current UK patient leaflet and professional product information [1,2], and it remains under additional monitoring so new safety information can be identified quickly.

The main ongoing risks to understand are not vague “toxicity” claims. They include persistent digestive symptoms, dehydration from vomiting or diarrhoea, gallstones, acute pancreatitis, diabetic eye disease complications, hypoglycaemia in people using insulin or sulfonylureas, rare serious eye problems such as NAION, and severe constipation or bowel obstruction symptoms. [1,2,3,4,5]

If a side effect continues for weeks, becomes harder to manage, or keeps returning after dose increases, the right response is a prescriber review. Long-term treatment should be tolerable and clinically supervised, not something you endure without support.

Who should take extra care before or during Wegovy treatment?

This article cannot assess whether Wegovy is suitable for you. That assessment depends on your medical history, medicines, pregnancy status, weight-related health profile and prescriber judgement.

You should tell your prescriber before or during treatment if you have a history of pancreatitis, diabetes, diabetic eye disease, kidney problems, delayed stomach emptying, gallbladder problems, severe digestive symptoms, planned surgery or anaesthesia, or if you use insulin, sulfonylureas, warfarin or other medicines affected by appetite, digestion or fluid loss. [1,2]

Wegovy should not be used during pregnancy. [1,3] If you wish to become pregnant, the patient leaflet says you should stop using Wegovy at least two months in advance. You should also tell your doctor straight away if you become pregnant, think you may be pregnant, or are planning a baby while using Wegovy. Wegovy should not be used while breastfeeding.

Can Wegovy affect mood or mental health?

The current UK regulatory position is more careful than some older online content suggests. The MHRA has reviewed reports involving GLP-1 receptor agonists and concluded that the available evidence did not support a causal link with suicide, suicidal thoughts, self-injury or depression, and no update to product information was required at that time. [13]

That does not mean mood symptoms should be ignored. Weight-loss treatment, appetite changes, body-image pressure, existing mental-health conditions and reduced food intake can all affect how someone feels. If you experience distressing mood changes, speak to a clinician. If you have thoughts of self-harm or feel at immediate risk, seek urgent help now through emergency services or a crisis support route.

 

Does Wegovy cause thyroid cancer?

This is another area where US-focused content can confuse UK readers. The current UK Wegovy patient leaflet used for this guide does not list thyroid cancer as a patient-facing side effect. [1] The professional product information states that thyroid C-cell tumours were seen in rodents and that the relevance for humans is considered low, but cannot be completely excluded. [2]

Do not use that as a reason to self-diagnose or dismiss symptoms. If you have a personal concern about thyroid disease, a history of thyroid cancer, or symptoms such as a new neck lump, persistent hoarseness or difficulty swallowing, discuss this with a prescriber or GP.

Reporting suspected side effects

If you think you have had a side effect from Wegovy, you can report it through the MHRA Yellow Card scheme. [1] Reporting does not replace medical advice, but it helps regulators monitor medicine safety.

Common questions

How we wrote this article

This article was created in line with our editorial standards. Medical information is checked against UK-relevant guidance and reliable sources, which may include the NHS, NICE, the MHRA, medicine safety information, recognised clinical guidance and peer-reviewed research.

Medical content is reviewed regularly and updated sooner if clinical, safety or regulation guidance changes. This article is general information, and not a substitute for personal advice from your own prescriber.

Something wrong or outdated? Email: support@lotusweightloss.co.uk

References

  1. eMC. Wegovy FlexTouch Patient Information Leaflet medicines.org.uk
  2. eMC. Wegovy FlexTouch Summary of Product Characteristics medicines.org.uk
  3. MHRA: GLP-1 medicines for weight loss and diabetes - what you need to know. gov.uk
  4. MHRA Drug Safety Update: strengthened warnings on acute pancreatitis gov.uk
  5. MHRA Drug Safety Update: GLP-1 receptor agonists - side effects and misuse reminder. gov.uk
  6. NICE TA875: Semaglutide for managing overweight and obesity. nice.org.uk
  7. NHS, Diarrhoea and vomiting nhs.uk
  8. NHS, Dehydration nhs.uk
  9. NHS: Constipation nhs.uk
  10. HS: Heartburn and acid reflux. nhs.uk
  11. NHS, Gallstones nhs.uk
  12. NHS: Acute cholecystitis nhs.uk
  13. MHRA: evidence review on GLP-1 receptor agonists and suicidal/self-injurious thoughts. gov.uk
PERSONAL ASSESSMENT

Is your next step
a suitability check?

Every consultation is reviewed by a qualified
prescriber to check whether weight loss treatment is right for you.

Start an assessment
Paul John
Paul John MPharm, IP

Paul John MPharm, IP is a Clinical Pharmacist Prescriber at Lotus Weight Loss with over 15 years of experience across community and NHS care. He has held national leadership roles in blood-borne virus services in Wales and has contributed to work recognised by the BMJ for clinical leadership.

View Paul John's profile